Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;19(2):71-72.
doi: 10.1038/s41582-022-00767-x.

Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?

Marwan N Sabbagh  1 , Boris DeCourt  2
Affiliations
Comment

Biomarker-based diagnosis of preclinical Alzheimer disease: time for the clinic?

Marwan N Sabbagh et al. Nat Rev Neurol. 2023 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

COMPETING INTERESTS: B.D. disclosed consulting for Seq Biomarque and TransDermix. M.N.S disclosed ownership interests (stock or stock options) in Athira Pharma, NeuroTau, Optimal Cognitive Health Company and uMethod Health; consulting for Alzheon, Biogen, Cortexyme, Eisai, Genentech, KeifeRx and T3D Therapeutics; and receipt of royalties from HarperCollins and Humanix.

Comment on

References

    1. GBD 2019 Dementia Forecasting Collaborators (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 10.1016/S2468-2667(21)00249–8 - DOI - PMC - PubMed
    1. DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener 14(1), 32. - PMC - PubMed
    1. Jack CR Jr, Knopman DS, Jagust WJ, et al. (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12(2), 207–16 - PMC - PubMed
    1. Jack CR Jr, Bennett DA, Blennow K, et al. (2016) A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87(5), 539–47 - PMC - PubMed
    1. Ossenkoppele R, Pichet Binette A, Groot C, et al. (2022) Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 28(11), 2381–2387 - PMC - PubMed

Publication types